Lam Research Corp (LRCX)
Official siteTECHNOLOGY • SEMICONDUCTOR EQUIPMENT & MATERIALS • NASDAQ
Market Cap: $263.36B
Last updated: Nov 17, 2026 at 4:44 PM ET
Lam Research Corp (LRCX) Statistics
Lam Research (LRCX) has a market cap of $263.36B and an enterprise value of $259.66B. Revenue grew 33.36% over the last 12 months from the 12 months before. Its return on invested capital of 47.89% compares with a 7.13% median across 10 similar companies.
Total Valuation
Enterprise value is 1.41% below the market cap, as cash exceeds debt.
| Market Cap | $263.36B |
|---|---|
| Enterprise Value | $259.66B |
| Latest price (Nov 17, 2026) | $210.69 |
Key Dates
The next earnings report is expected on Jan 26, 2027, covering the quarter ending Dec 31, 2026. The next ex-dividend date is Dec 2, 2026.
| Next Earnings Date | Jan 26, 2027 (expected) |
|---|---|
| Last Earnings Date | Oct 21, 2026 |
| Next Ex-Dividend Date | Dec 2, 2026 |
| Next Payment Date | Jan 6, 2027 |
| Fiscal Year End | June |
Valuation Ratios
Sales and book value multiples are 10.1x and 18.9x. Its year-end P/E ranged from 7.8x to 34.9x from 2016 to 2025.
| P/E Ratio | 31.2x |
|---|---|
| Forward P/E | 21.3x |
| P/S Ratio | 10.1x |
| Forward P/S | 7.4x |
| P/B Ratio | 18.9x |
| P/TBV Ratio | 22.0x |
| P/FCF Ratio | 40.3x |
| P/OCF Ratio | 34.8x |
| PEG Ratio | 1.2 |
Enterprise Valuation
Counting debt and cash, the company is valued at 25.5x EBITDA and 39.7x free cash flow.
| EV / Earnings | 30.7x |
|---|---|
| EV / Sales | 9.9x |
| EV / EBITDA | 25.5x |
| EV / EBIT | 26.7x |
| EV / FCF | 39.7x |
Price Statistics
The stock is up 42.51% over 52 weeks and trades 22.95% below its 50-day average.
| Beta (1Y) | 3.35 |
|---|---|
| 52-Week Change | +42.51% |
| 1-Month Change | -22.60% |
| 3-Month Change | -31.33% |
| 6-Month Change | -22.80% |
| 5-Year Change | +324.28% |
| 10-Year Change | +2368.61% |
| Total Return (1Y) | +43.28% |
| Total Return (3Y CAGR) | +45.39% |
| Total Return (5Y CAGR) | +28.31% |
| Return vs SPY (1Y) | +35.94% |
| Max Drawdown (1Y) | -57.21% |
| Max Drawdown (3Y) | -57.21% |
| Sharpe Ratio (1Y) | 0.56 |
| Correlation with SPY (1Y) | 0.67 |
| 50-Day Average | $273.46 |
| 200-Day Average | $283.33 |
| 52-Week Range | $134.88 to $438.03 |
| RSI (14 Days) | 37.6 |
| Average Volume (20 Days) | 14.05M |
The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Current assets cover 2.48x current liabilities, and total debt is 0.27x shareholder equity.
| Current Ratio | 2.48x |
|---|---|
| Quick Ratio | 1.86x |
| Debt / Equity | 0.27x |
| Debt / EBITDA | 0.37x |
| Debt / FCF | 0.57x |
Returns and Efficiency
Return on invested capital is 47.89% over the last 12 months, against a 5-year average of 37.08%.
| Return on Equity (ROE) | 60.75% |
|---|---|
| Return on Assets (ROA) | 32.06% |
| Return on Invested Capital (ROIC) | 47.89% |
| Return on Capital Employed (ROCE) | 51.03% |
| ROE (5Y Average) | 57.14% |
| ROA (5Y Average) | 25.44% |
| ROIC (5Y Average) | 37.08% |
| Asset Turnover | 1.08x |
| Inventory Turnover | 2.90x |
| Receivables Turnover | 4.75x |
| Cash Conversion Cycle | 161 days |
Taxes
Income tax took 13.03% of pretax income over the last 12 months.
| Income Tax (TTM) | $1.27B |
|---|---|
| Effective Tax Rate | 13.03% |
Scores
LRCX has an Altman Z-Score of 17.39, in the safe zone above 2.99, and a Piotroski F-Score of 8 of 9, in the strong band of 8 or 9.
Altman Z-ScoreDistress below 1.81Safe above 2.99
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Altman Z-Score | 17.39 |
|---|---|
| Altman Z Zone | Safe |
| Piotroski F-Score | 8 of 9 |
| Piotroski Strength | Strong |
Income Statement
Revenue was $26.13B over the last 12 months.
| Revenue | $26.13B |
|---|---|
| Revenue Growth (YoY) | +33.36% |
| Gross Profit | $13.34B |
| Operating Income | $9.65B |
| Pretax Income | $9.72B |
| Net Income | $8.45B |
| EBITDA | $10.18B |
| EBIT | $9.72B |
| Reported EPS (TTM) | $6.76 |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
Shareholder equity funds 52.79% of the $26.35B in total assets.
| Cash and Equivalents | $7.44B |
|---|---|
| Total Debt | $3.74B |
| Net Cash | $3.70B |
| Net Cash Per Share | $2.96 |
| Working Capital | $10.81B |
| Shareholder Equity | $13.91B |
| Book Value Per Share | $11.12 |
| Tangible Book Value | $12.00B |
| Tangible Book Per Share | $9.59 |
| Total Assets | $26.35B |
| Total Liabilities | $12.44B |
Balance sheet as of Sep 30, 2026.
Cash Flow
After $1.04B of capital spending, operating cash flow left $6.54B of free cash flow.
| Operating Cash Flow | $7.58B |
|---|---|
| Capital Expenditures | $1.04B |
| Free Cash Flow | $6.54B |
| FCF Per Share | $5.22 |
| Depreciation and Amortization | $461.96M |
| Dividends Paid | $1.30B |
| Share Repurchases | $3.90B |
Trailing 12 months through Sep 30, 2026.
Margins
The operating margin is 36.95%, against a 5-year average of 31.37%.
| Gross Margin | 51.05% |
|---|---|
| Operating Margin | 36.95% |
| Pretax Margin | 37.18% |
| Net Margin | 32.34% |
| EBITDA Margin | 38.95% |
| EBIT Margin | 37.18% |
| FCF Margin | 25.02% |
| Gross Margin (5Y Average) | 47.36% |
| Operating Margin (5Y Average) | 31.37% |
| Net Margin (5Y Average) | 27.73% |
Growth
Revenue grew 10.06% a year over 3 years, and EPS 19.51% a year.
| Revenue Growth (3Y CAGR) | +10.06% |
|---|---|
| Revenue Growth (5Y CAGR) | +9.70% |
| EPS Growth (3Y CAGR) | +19.51% |
| EPS Growth (5Y CAGR) | +16.35% |
| FCF Growth (3Y CAGR) | +1.50% |
| FCF Growth (5Y CAGR) | +8.59% |
| Operating Income Growth (3Y CAGR) | +16.58% |
Dividends and Yields
LRCX pays out 16.86% of earnings as dividends.
| Dividend Per Share (Annual) | $1.44 |
|---|---|
| Dividend Yield | 0.68% |
| Payment Schedule | Quarterly |
| Dividend Growth (3Y CAGR) | +14.96% |
| Dividend Growth (5Y CAGR) | +14.87% |
| Payout Ratio | 16.86% |
| FCF Payout Ratio | 19.95% |
| Earnings Yield | 3.21% |
| FCF Yield | 2.48% |
| Buyback Yield | 1.41% |
| Shareholder Yield | 1.91% |
Stock Splits
The last split was a 10-for-1 forward split on Oct 3, 2024.
| Last Split Date | Oct 3, 2024 |
|---|---|
| Split Type | Forward split |
| Split Ratio | 10:1 |
Peer Position
Against 11 similar companies, LRCX has the 6th highest P/E.
P/E RatioPeer median 30.8x
P/S RatioPeer median 7.8x
ROICPeer median 7.13%
Revenue Growth (Trailing 4 Quarters, YoY)Peer median +15.81%
Dividend YieldPeer median 0.00%
| P/E Ratio | 31.2x vs 30.8x median |
|---|---|
| P/S Ratio | 10.1x vs 7.8x median |
| ROIC | 47.89% vs 7.13% median |
| Revenue Growth (Trailing 4 Quarters, YoY) | +33.36% vs +15.81% median |
| Dividend Yield | 0.68% vs 0.00% median |
Analyst Forecast
Consensus estimates put revenue growth at 35.41% and EPS growth at 45.00% a year over the next 2 fiscal years.
| Revenue Growth Forecast (2Y CAGR) | +35.41% |
|---|---|
| EPS Growth Forecast (2Y CAGR) | +45.00% |
Price Target
Analyst price targets are part of paid GNG plans. See plans
GNG Valuation
| GNG view | Overvalued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About LRCX
What is LRCX's market cap?
Lam Research has a market cap of $263.36B. Its enterprise value, which adds debt and subtracts cash, is $259.66B.
What is LRCX's P/E ratio?
Lam Research has a trailing P/E ratio of 31.2x and a forward P/E of 21.3x.
How many shares of LRCX are outstanding?
Lam Research has 1.25B shares outstanding. The count is down 1.07% from a year earlier.
Does LRCX pay a dividend?
Yes. Lam Research pays $1.44 a share a year, a dividend yield of 0.68%.
How much debt does LRCX have?
Lam Research has $3.74B of total debt and $7.44B of cash and equivalents, a net cash position of $3.70B.
LRCX pages: Overview, Dividends, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors